Back to search
FDAFDA · Food and drugs·Recall number Z-1635-2024

Palindrome Precision H Chronic Catheter Kit 14.5 Fr/Ch (4.8mm) x 23 cm (Symmetrical Tip, Heparin Coating and Tal VenaTrac Stylet- Intended for acute and chronic hemodialysis, apheresis, and infusion. Model Number (CFN): 8888145044CP

Published May 1, 2024 · Recall initiated: March 15, 2024

Summary

FDA records medical device Class II recall Z-1635-2024, published May 1, 2024 and initiated March 15, 2024. Recalling firm: Covidien LP; Status: Ongoing; Reported quantity: 878 units; Lot: GTIN: 20884521158082, 10884521158085 Lot Number: 2228000089, 2201700103, 2228000074. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Products may not be heparin coated as indicated on the label-leads to a potential loss of benefit due to the absence of the heparin coating

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Covidien LP
Distributor
Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Canary Islands, Denmark, Faroe Islands, France, Germany, Greece, Iceland, Ireland, Italy, Mayotte, Norway, Poland, Reunion, South Africa, Spain, Sweden, United Kingdom.
Lot
GTIN: 20884521158082, 10884521158085 Lot Number: 2228000089, 2201700103, 2228000074
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Palindrome Precision H Chronic Catheter Kit 14.5 Fr/Ch (4.8mm) x 23 cm (Symmetrical Tip, Heparin Coating and Tal VenaTrac Stylet- Intended for acute and chronic hemodialysis, apheresis, and infusion. Model Number (CFN): 8888145044CP recalled?

Yes. FDA published recall Z-1635-2024 on May 1, 2024. Reported hazard: Products may not be heparin coated as indicated on the label-leads to a potential loss of benefit due to the absence of the heparin coating

What should I do if I have this product?

Voluntary: Firm initiated · Letter